Itonis, Inc.
OTC: ITNS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mark H. Cheung
- Employees
- 3
- Headquarters
- Laguna Hills, United States
- IPO year
- 2007
- Market cap
- $457.0K
- Website
- https://www.itonisholdings.com
Loading ITNS…
Loading profile data…Frequently asked questions about ITNS
What does Itonis, Inc. (ITNS) do?
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl produ...
Where does ITNS trade?
Itonis, Inc. (ITNS) trades on the Other OTC.
What sector is ITNS in?
Itonis, Inc. (ITNS) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Itonis, Inc.?
Mark H. Cheung is the chief executive officer of Itonis, Inc. (ITNS).
Where is Itonis, Inc. headquartered?
Itonis, Inc. is headquartered in United States.
Does ITNS pay a dividend?
Itonis, Inc. (ITNS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ITNS go public?
Itonis, Inc. (ITNS) completed its initial public offering in 2007.